BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38140650)

  • 1. Elevated Plasma Protein Carbonyl Concentration Is Associated with More Abnormal White Matter in People with HIV.
    Riggs PK; Anderson AM; Tang B; Rubin LH; Morgello S; Marra CM; Gelman BB; Clifford DB; Franklin D; Heaton RK; Ellis RJ; Fennema-Notestine C; Letendre SL
    Viruses; 2023 Dec; 15(12):. PubMed ID: 38140650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional brain gray and white matter changes in perinatally HIV-infected adolescents.
    Sarma MK; Nagarajan R; Keller MA; Kumar R; Nielsen-Saines K; Michalik DE; Deville J; Church JA; Thomas MA
    Neuroimage Clin; 2014; 4():29-34. PubMed ID: 24380059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma inflammatory biomarkers link to diffusion tensor imaging metrics in virally suppressed HIV-infected individuals.
    Chang K; Premeaux TA; Cobigo Y; Milanini B; Hellmuth J; Rubin LH; Javandel S; Allen I; Ndhlovu LC; Paul R; Valcour V
    AIDS; 2020 Feb; 34(2):203-213. PubMed ID: 31634200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleic acid oxidation is associated with biomarkers of neurodegeneration in CSF in people with HIV.
    Ellis RJ; Moore DJ; Sundermann EE; Heaton RK; Mehta S; Hulgan T; Samuels D; Fields JA; Letendre SL
    Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 33055205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic and intrathecal immune activation in association with cerebral and cognitive outcomes in paediatric HIV.
    Blokhuis C; Peeters CFW; Cohen S; Scherpbier HJ; Kuijpers TW; Reiss P; Kootstra NA; Teunissen CE; Pajkrt D
    Sci Rep; 2019 May; 9(1):8004. PubMed ID: 31142789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of comorbidity burden and age on brain integrity in HIV.
    Saloner R; Heaton RK; Campbell LM; Chen A; Franklin D; Ellis RJ; Collier AC; Marra C; Clifford DB; Gelman B; Sacktor N; Morgello S; McCutchan JA; Letendre S; Grant I; Fennema-Notestine C;
    AIDS; 2019 Jun; 33(7):1175-1185. PubMed ID: 30870195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes.
    Pietroboni AM; Carandini T; Colombi A; Mercurio M; Ghezzi L; Giulietti G; Scarioni M; Arighi A; Fenoglio C; De Riz MA; Fumagalli GG; Basilico P; Serpente M; Bozzali M; Scarpini E; Galimberti D; Marotta G
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):280-287. PubMed ID: 30343433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher subcortical and white matter cerebral blood flow in perinatally HIV-infected children.
    Blokhuis C; Mutsaerts HJMM; Cohen S; Scherpbier HJ; Caan MWA; Majoie CBLM; Kuijpers TW; Reiss P; Wit FWNM; Pajkrt D
    Medicine (Baltimore); 2017 Feb; 96(7):e5891. PubMed ID: 28207506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct Effects of Selective Serotonin Reuptake Inhibitors and Serotonin-Norepinephrine Reuptake Inhibitors on Soluble Biomarkers in Blood and Cerebrospinal Fluid of People With HIV.
    Trunfio M; Tang B; Iudicello JE; Ma Q; Franklin DR; Cookson D; Riggs PK; Cherner M; Moore DJ; Heaton RK; Letendre SL; Ellis RJ
    J Infect Dis; 2024 May; 229(5):1266-1276. PubMed ID: 38059529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical factors related to brain structure in HIV: the CHARTER study.
    Jernigan TL; Archibald SL; Fennema-Notestine C; Taylor MJ; Theilmann RJ; Julaton MD; Notestine RJ; Wolfson T; Letendre SL; Ellis RJ; Heaton RK; Gamst AC; Franklin DR; Clifford DB; Collier AC; Gelman BB; Marra C; McArthur JC; McCutchan JA; Morgello S; Simpson DM; Grant I;
    J Neurovirol; 2011 Jun; 17(3):248-57. PubMed ID: 21544705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma and Cerebrospinal Fluid Biomarkers Predict Cerebral Injury in HIV-Infected Individuals on Stable Combination Antiretroviral Therapy.
    Anderson AM; Harezlak J; Bharti A; Mi D; Taylor MJ; Daar ES; Schifitto G; Zhong J; Alger JR; Brown MS; Singer EJ; Campbell TB; McMahon DD; Buchthal S; Cohen R; Yiannoutsos C; Letendre SL; Navia BA;
    J Acquir Immune Defic Syndr; 2015 May; 69(1):29-35. PubMed ID: 25622053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrophic brain signatures of mild forms of neurocognitive impairment in virally suppressed HIV infection.
    Nichols MJ; Gates TM; Soares JR; Moffat KJ; Rae CD; Brew BJ; Cysique LA
    AIDS; 2019 Jan; 33(1):55-66. PubMed ID: 30325766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-associated alterations in normal-appearing white matter: a voxel-wise diffusion tensor imaging study.
    Stebbins GT; Smith CA; Bartt RE; Kessler HA; Adeyemi OM; Martin E; Cox JL; Bammer R; Moseley ME
    J Acquir Immune Defic Syndr; 2007 Dec; 46(5):564-73. PubMed ID: 18193498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Eye as a Window to the Brain: Neuroretinal Thickness Is Associated With Microstructural White Matter Injury in HIV-Infected Children.
    Blokhuis C; Demirkaya N; Cohen S; Wit FW; Scherpbier HJ; Reiss P; Abramoff MD; Caan MW; Majoie CB; Verbraak FD; Pajkrt D
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(8):3864-71. PubMed ID: 27447087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular injury markers associated with cognitive impairment in people with HIV on suppressive antiretroviral therapy.
    Guha D; Misra V; Yin J; Horiguchi M; Uno H; Gabuzda D
    AIDS; 2023 Nov; 37(14):2137-2147. PubMed ID: 37503603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of White Matter Hyperintensities With HIV Status and Vascular Risk Factors.
    Mina Y; Wu T; Hsieh HC; Hammoud DA; Shah S; Lau CY; Ham L; Snow J; Horne E; Ganesan A; Rapoport SI; Tramont EC; Reich DS; Agan BK; Nath A; Smith BR;
    Neurology; 2021 Apr; 96(14):e1823-e1834. PubMed ID: 33637630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension.
    Al-Janabi OM; Brown CA; Bahrani AA; Abner EL; Barber JM; Gold BT; Goldstein LB; Murphy RR; Nelson PT; Johnson NF; Shaw LM; Smith CD; Trojanowski JQ; Wilcock DM; Jicha GA
    J Alzheimers Dis; 2018; 66(3):1095-1104. PubMed ID: 30400099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer's disease.
    Wang Q; Wang Y; Liu J; Sutphen CL; Cruchaga C; Blazey T; Gordon BA; Su Y; Chen C; Shimony JS; Ances BM; Cairns NJ; Fagan AM; Morris JC; Benzinger TLS
    Neuroimage Clin; 2019; 22():101767. PubMed ID: 30901713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between cerebrospinal fluid and plasma neurofilament light protein in treated HIV infection: results from the COBRA study.
    Alagaratnam J; De Francesco D; Zetterberg H; Heslegrave A; Toombs J; Kootstra NA; Underwood J; Gisslen M; Reiss P; Fidler S; Sabin CA; Winston A
    J Neurovirol; 2022 Feb; 28(1):54-63. PubMed ID: 34874540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. White Matter Abnormalities Linked to Interferon, Stress Response, and Energy Metabolism Gene Expression Changes in Older HIV-Positive Patients on Antiretroviral Therapy.
    Solomon IH; Chettimada S; Misra V; Lorenz DR; Gorelick RJ; Gelman BB; Morgello S; Gabuzda D
    Mol Neurobiol; 2020 Feb; 57(2):1115-1130. PubMed ID: 31691183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.